The GLP-1 peptide market is doing $60B in annual revenue.
That's roughly what OpenAI and Anthropic are pulling in combined.
One molecule class. And manufacturing still can't keep up with demand.
Aaron Weaver on why peptides are the most underpriced category in biotech right now.